{"slug":"adamax","seoKey":"adamax","displayName":"Adamax","codes":[],"synonyms":["adamantyl-Semax (descriptive vendor label)","N-adamantyl Semax analogue","Ac-MEHFPGP-AG-NH2 (vendor notation, ambiguous and unverified)","Адамакс (Russian transliteration used in trade listings)"],"legalClass":"research_chemical","identifiers":{},"approvals":[{"market":"US","status":"not_approved","note":"Not approved in any form and not registered as a substance. Three openFDA endpoints returned no match on 2026-09-06, and the substance does not appear in the compounding advisory committee briefing material of July 2026, which did assess related substances.","source":"https://api.fda.gov/drug/label.json?search=openfda.substance_name:%22Adamax%22"},{"market":"EU","status":"not_approved","note":"No authorised medicinal product, no assessment report and no pending procedure. No entry found on 2026-09-06.","source":"https://www.ema.europa.eu/en/medicines?search_api_fulltext=Adamax"},{"market":"DE","status":"not_approved","note":"Neither a national nor an EU marketing authorisation exists, so the substance is not a marketable medicinal product. Placing it on the market as a food or food supplement would equally not be permitted. No entry found on 2026-09-06.","source":"https://www.ema.europa.eu/en/medicines?search_api_fulltext=Adamax"},{"market":"UK","status":"not_approved","note":"No marketing authorisation, no registered product and no clinical trial registered in the United Kingdom. No entry found on 2026-09-06.","source":"https://products.mhra.gov.uk/search/?search=Adamax"},{"market":"AU","status":"not_approved","note":"Not named in the Poisons Standard; the full text was searched on 2026-09-06 without a hit. Absence of a listing is not a release: unapproved therapeutic goods remain subject to registration requirements.","source":"https://www.legislation.gov.au/F2026L00633/asmade"},{"market":"CA","status":"not_approved","note":"No marketing authorisation and no entry in the drug product database; the active ingredient query returned an empty result on 2026-09-06.","source":"https://health-products.canada.ca/api/drug/activeingredient/?lang=en&type=json&ingredientname=Adamax"},{"market":"CH","status":"not_approved","note":"No marketing authorisation. No entry found in the Swiss medicinal product information on 2026-09-06.","source":"https://www.swissmedicinfo.ch/"}],"devStage":"preclinical","strongestEvidence":"none","wada":{"status":"prohibited","section":"S0","listYear":2026,"source":"https://www.wada-ama.org/en/prohibited-list"},"trials":[],"sameAs":[],"lastVerified":"2026-09-06","version":"1.0","published":true,"locale":"en","title":"Adamax: what the studies show, status and safety","summary":"Adamax is sold as a nootropic peptide, but it has never been studied. Six literature and substance databases were searched on 6 September 2026 and held nothing about it, and the sellers say the same in their own words. Even its structure is unsettled. No health authority anywhere has approved it, so it is banned in sport at all times.","updated":"2026-09-06","url":"https://mypep.app/peptides/adamax"}